Profile
ABOS VRTX REGN VRNA ARGX ALNY
Company Name Acumen Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $145.38M $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.06K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Daniel J. O'Connell Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ABOS VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
ABOS VRTX REGN VRNA ARGX ALNY
Last Close $1.58 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $2.39 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.9 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -33.89 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 75.56 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ABOS VRTX REGN VRNA ARGX ALNY
1 Month Return -22.17 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 10.49 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 47.66 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 9.34 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -8.14 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -33.89 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABOS VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -1405.19 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
ABOS VRTX REGN VRNA ARGX ALNY
Asset Growth -22.94 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth - 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year -100 % 73.64 % - 775.72 %
Revenue 10 Year -100 % 285.02 % - 2487.4 %
EBIT Growth -89.73 % 9.09 % -131.37 % 24.59 %
Net Income Growth -95.39 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 35.14 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -517.86 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -517.86 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -86.49 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -100.2 % - -143.33 % -107.98 %
Operating 3 Year CFG -206.07 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -503.71 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -503.71 % -100 % 40.15 % 97.08 %
EPS Growth -58.33 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth -58.33 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -44.97 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -48.52 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share 860.1 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 860.1 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 4.27 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -100.14 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ABOS VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -93.76 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -97.41 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -114.94 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 96.47 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -401.02 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.06 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -2.04 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -2.04 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 209.02 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.07 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -401.02 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -1.17 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -1.18 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -1.18 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
ABOS VRTX REGN VRNA ARGX ALNY
Revenue $0B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $0B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 0% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $-0.1B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0.1B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -1.71 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
ABOS VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.03B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.06B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $0.18B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0.2B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0.03B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $0.24B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
ABOS VRTX REGN VRNA ARGX ALNY
Net Income $-0.1B $3.95B $4.5B $-0.17B $0.83B $0.31B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.09B $3.63B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $-0B $-0.44B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 23.82
AARD Aardvark Therapeutics, Inc. Common Stock 12.1
ABCL AbCellera Biologics Inc. 3.1
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.01
ABIO ARCA biopharma, Inc. 28.8
ABPWW 0.0131
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 3.98
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.99
ACAD ACADIA Pharmaceuticals Inc. 22.03
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.91
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.2
ACIU AC Immune SA 2.99
ACLX Arcellx, Inc. 68.5
ETFs With Exposure to ABOS
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00016 262.96
VTI Vanguard Total Stock Market Index Fund 0.00011 336.65
IBB iShares Biotechnology ETF 0.01258 172.5
IWN iShares Russell 2000 Value ETF 0.00035 199.97
BIB ProShares Ultra Nasdaq Biotechnology 0.00535472 84.7191
VXF Vanguard Extended Market Index Fund 0.00082 216.28
HDG ProShares Hedge Replication ETF 0.000269689 52.7
UWM ProShares Ultra Russell2000 0.00157102 53.08
VTHR Vanguard Russell 3000 Index Fund 0 301.597
IWC iShares Micro-Cap ETF 0.02 166.03
URTY ProShares UltraPro Russell2000 0.00125687 63.07
VTWV Vanguard Russell 2000 Value Index Fund 0.00373 176.213
CSML IQ Chaikin U.S. Small Cap ETF 0.17 34.9484
VTWO Vanguard Russell 2000 Index Fund 0.00168 106.26
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 49.73
VUN.TO Vanguard U.S. Total Market Index ETF 0.00011 124.53
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00011 116.8
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00017 113.38
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00017 113.36
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00009 52.22
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00009 52.21
VBINX Vanguard Balanced Index Fund Investor Shares 0.00009 52.21
VGRO.TO Vanguard Growth ETF Portfolio 0.00004 44.16
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00005 55.46
VBAL.TO Vanguard Balanced ETF Portfolio 0.00003 37.77
VCNS.TO Vanguard Conservative ETF Portfolio 0.00002 32.11
VCIP.TO Vanguard Conservative Income ETF Portfolio 0.00001 27.4
VRIF.TO Vanguard Retirement Income ETF Portfolio 0.00001 27.01
BMED BlackRock Future Health ETF 0.03 30.48
DFAU Dimensional US Core Equity Market ETF 0.00048189 47.29
IBBQ Invesco Nasdaq Biotechnology ETF 0.017 29.429
DFAT Dimensional U.S. Targeted Value ETF 0.00000769 66.28
DFAS Dimensional U.S. Small Cap ETF 0.0001142 75.67
DFAC Dimensional U.S. Core Equity 2 ETF 0.0000579 40.79
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03546 7.345
VTSAX Vanguard Total Stock Market Index Fund 0.00011 163.89
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01585 8.7175
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00082 164.01
VITSX Vanguard Total Stock Market Index Fund 0.00011 163.92
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.01585 8.684
IBRN iShares Neuroscience and Healthcare ETF 0.17376 31.5777
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000123949 16.45
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00082 164.02
AVSC Avantis U.S. Small Cap Equity ETF 0 64.82
VTS.AX Vanguard US Total Market Shares Index ETF 0.00011 474.81
DCOR Dimensional ETF Trust 0.00005219 75.52
VEMPX Vanguard Extended Market Index InstlPlus 0.00082 404.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00011 307.49
RSSL Global X Funds 0 102.97
DXUV Dimensional ETF Trust 0.0000186 62.51
Unlock